Masoondarou

Masoon Darou is a prominent Iranian biopharmaceutical company dedicated to the development and production of advanced biological products, including recombinant proteins and vaccines. Established in 2005, the company operates state-of-the-art GMP-certified facilities to manufacture a diverse portfolio that addresses critical needs in oncology, hematology, and neurology. Their flagship products include Masport, a botulinum toxin type A, and Masvac, a recombinant hepatitis B vaccine. Masoon Darou focuses on providing high-quality, cost-effective biosimilars and biological therapies for both the domestic Iranian market and international export. The company is recognized for its technical expertise in cell culture and protein purification, positioning itself as a key player in the Middle Eastern biotechnology sector.